How to estimate bleeding risk in mild bleeding disorders

Journal of Thrombosis and Haemostasis

Volumn 5, Issue SUPPL. 1, 2007, Pages 157-166

  Rodeghiero, Francisco ^a   Tosetto, A ^a   Castaman, G ^a  

^a SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Bleeding questionnaire; Bleeding risk; Diagnosis; Hemorrhagic disorders; Inherited platelet disorders; von Willebrand disease

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; VON WILLEBRAND FACTOR;

ANAMNESIS; BLEEDING DISORDER; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BLOOD CLOTTING FACTOR 11 DEFICIENCY; BLOOD CLOTTING FACTOR 5 DEFICIENCY; BLOOD CLOTTING FACTOR 7 DEFICIENCY; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSFIBRINOGENEMIA; FREQUENCY ANALYSIS; GENETIC ANALYSIS; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROBABILITY; PROTHROMBIN DEFICIENCY; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; RISK ASSESSMENT; STANDARDIZATION; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; HEMORRHAGE; HUMANS; SEVERITY OF ILLNESS INDEX;

EID: 34250696130     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02520.x     Document Type: Review

References (40)

1. Wintrobe MM. Clinical Hematology. Chapters 17-18, 5th edn., Philadelphia, PA: Lea & Febiger, 1956.
2. Miale JB. Laboratory Medicine Hematology. Chapter 14, 3rd edn, St Louis, MO: Mosby Company, 1967.
3. James AH, Ragni MV, Picozzi VJ. Bleeding disorders in premenopausal women: (another) public health crisis for Hematology?. Hematology, Am Soc Hematol Educ Program 2006; 474-85.
4. Wahlberg T, Blomback M, Hall P, Axelsson G. Application of indicators, predictors and diagnostic indices in coagulation disorders. I. Evaluation of a self-administered questionnaire with binary questions. Methods Inf Med 1980; 19: 194-200.
5. Sramek A, Eikenboom JC, Briet E, Vandenbroucke JP, Rosendaal FR. Usefulness of patient interview in bleeding disorders. Arch Intern Med 1995; 155: 1409-15.
6. Mauser Bunschoten EP, van Houwelingen JC, Sjamsoedin Visser EJ, van Dijken PJ, Kok AJ, Sixma JJ. Bleeding symptoms in carriers of hemophilia A and B. Thromb Haemost 1988; 59: 349-52.
7. Friberg B, Orno AK, Lindgren A, Lethagen S. Bleeding disorders among young women: A population-based prevalence study. Acta Obstet Gynecol Scand 2006; 85: 200-6.
8. Rodeghiero F, Castaman G, Tosetto A, Battle J, Baudo F, Cappelletti A, Casana P, De Bosch N, Eikenboom JC, Federici AB, Lethagen S, Linari S, Srivastava A. The discriminant power of bleeding history for the diagnosis of von Willebrand disease type 1: An international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
9. Hedlund-Treutiger I, Revel-Vilk S, Blanchette VS, Curtin JA, Lillicrap D, Rand ML. Reliability and reproducibility of classification of children as "bleeders"versus "non-bleeders" using a questionnaire for significant mucocutaneous bleeding. J Pediatr Hematol Oncol 2004; 26: 488-91.
10. Leung LLK. Perioperative evaluation of bleeding diathesis. Hematology Am Soc Hematol Educ Program 2006; 457-61.
11. Vandenbroucke JP, Rosing J, Bloemenkamp KW, Middeldorp S, Helmerhorst FM, Bouma BN, Rosendaal FR. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001; 344: 1527-35.
12. Tosetto A, Rodeghiero F, Castaman G, Goodeve A, Federici AB, Battle J, Meyer D, Fressinaud E, Mazurier C, Goudemand J, Eikenboom JC, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost 2006; 4: 766-73.
13. Koreth R, Weinert C, Weisdorf DJ, Key NS. Measurement of bleeding severity: A critical review. Transfusion 2004; 44: 605-17.
14. Nosek-Cenkowska B, Cheang MS, Pizzi NJ, Israels ED, Gerrard JM. Bleeding/ bruising symptomatology in children with and without bleeding disorders. Thromb Haemost 1991; 65: 237-41.
15. McKay H, Derome F, Haq MA, Whittaker S, Arnold E, Adam F, Heddle NM, Rivard GE, Hayward CP. Bleeding risks associated with inheritance of the Quebec platelet disorder. Blood 2004; 104: 159-65.
16. Coller BS, Schneiderman PI. Clinical evaluation of hemorrhagic disorders: The bleeding history and differential diagnosis of purpura. In: Hoffman R, Benz EJ, Shattil JS, Furie B, Cohen JC, Silberstein LE, McGlave P, eds.. Hematology. Basic Principles and Practice. Philadelphia, PA: Elsevier Churchill Livingstone 2007; in press.
17. Castaman G, Rodeghiero F, Tosetto A, Cappelletti A, Baudo F, Eikenboom JCJ, Federici AB, Lethagen S, Linari S, Lusher J, Nishino M, Petrini P, Srivastava A, Ungerstedt JS. Hemorrhagic symptoms and bleeding risk in obligatory carriers of type 3 von Willebrand Disease: An International, Multicenter Study. J Thromb Haemost 2006; 4: 2164-9.
18. Higham JM, O'Brien PMS, Shaw RWL. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
19. Hallberg L, Hogdal A-M, Nilsson L, Rybo G. Menstrual blood loss-A population study. Acta Obstet Gynaecol Scand 1966; 45: 320-51.
20. Kadir RA, Economides DL, Sabin CA, Pollard D, Lee CA. Assessment of menstrual blood loss and gynaecological problems in patients with inherited bleeding disorders. Haemophilia 1998; 5: 40-8.
21. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998; 351: 485-9.
22. Edlund M, Blomback M, von Schoultz B, Andersson O. On the value of menorrhagia as a predictor for coagulation disorders. Am J Hematol 1996; 53: 234-8.
23. Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia 1999; 5: 313-7.
24. Rodeghiero F, Castaman G. Congenital von Willebrand disease type 1: definition, phenotypes, clinical and laboratory assessment. Best Practice & Research Clinical Haematology 2001; 14: 321-35.
25. Sadler JE, Rodeghiero F. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 3: 775-7.
26. Bowman M, James P, Godwin M, Rapson D, Lillicrap D. The prevalence of von Willebrand disease in the primary Care. Blood 2005; 106: 1780.
27. Goodeve A, Eikenboom J, Castaman G, Rodeghiero F, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Schneppenheim R, Budde U, Ingerslev J, Habart D, Vorlova Z, Holmberg L, Lethagen S, Pasi J, Hill F, Soteh MH, Baronciani L, et al. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD). Blood 2007; 109: 112-21.
28. Tosetto A, Rodeghiero F, Castaman G, Bernardi M, Bertoncello K, Goodeve A, Federici AB, Batlle J, Meyer D, Mazurier C, Goudemand J, Eikenboom J, Schneppenheim R, Budde U, Ingerslev J, Vorlova Z, Habart D, Holmberg L, Lethagen S, Pasi J, et al. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: Results from a multicenterEuropean study (MCMDM-1VWD). J Thromb Haemost 2007; 5: 715-21.
29. Plug I, Mauser-Bunschoten EP, Brockër- Vriends AHJT, Ploos Van Amstel HK, van der Bom JG, van Diemen-Homan JEM, Willemse J, Rosendaal FR. Bleeding in carriers of hemophilia. Blood 2006; 108: 52-6.
30. Acharya SS, Coughlin A, DiMichele DM, The North American Rare Bleeding Disorders Study Group. Rare bleeding disorder registry: Deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. J Thromb Haemost 2003; 2: 248-56.
31. Mariani G, Dolce A. Congenital FVII deficiency. In: Lee CA, Berntorp EE, Hoots WH, eds.. Textbook of Hemophilia. Oxford: Blackwell Publishing, 2005: 311-4.
32. Seligsohn U. Factor XI deficiency. In: Lee CA, Berntorp EE, Hoots WH, eds.. Textbook of Hemophilia. Oxford: Blackwell Publishing, 2005: 321-7.
33. Asakai R, Chung DW, Ratnoff OD, Davie EW. Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations. Proc Natl Acad Sci USA 1989; 86: 7667-71.
34. Kravtsov DV, Wu W, Meijers JC, Sun MF, Blinder MA, Dang TP, Wang H, Gailami D. Dominant factor XI deficiency caused by mutations in the factor XI catalytic domain. Blood 2004; 104: 128-34.
35. Kravtsov DV, Monahan PE, Gailani D. A classification system for cross-reactive material-negative factor XI deficiency. Blood 2005; 105: 4671-3.
36. Bolton-Maggs PHB, Chalmers EA, Collins PW, Harrison P, Kitchen S, Liesner RJ, Minford A, Mumford AD, Parapia LA, Perry DJ, Watson SP, Wilde JT, Williams MD. A review of inherited platelet disorders with guidelines for their management on behalf of the UKHCDO. Br J Haematol 2006; 135: 603-33.
37. Weiss HJ, Vicic WJ, Lages BA, Rogers J. Isolated deficiency of platelet procoagulant activity. Am J Med 1979; 67: 206-13.
38. Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: Studies on one hundred six patients. Blood 1987; 70: 620-3.
39. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Haemost 1990; 16: 1-20.
40. Lind SE. The bleeding time does not predict surgical bleeding. Blood 1991; 77: 2547-52.